NK cells and γδ T cells mediate resistance to polyomavirus-induced tumors

PLoS Pathogens

Volumn 6, Issue 5, 2010, Pages 1-13

  Mishra, Rabinarayan ^a   Chen, Alex T ^a   Welsh, Raymond M ^a   Szomolanyi Tsuda, Eva ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN RAE 1; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL KILLING; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; GAMMA DELTA T LYMPHOCYTE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; POLYOMAVIRUS INFECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SALIVARY GLAND TUMOR; T LYMPHOCYTE; TUMOR IMMUNITY; VIRUS CARCINOGENESIS;

MUS; POLYOMAVIRUS;

EID: 77954041995     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000924     Document Type: Article

References (48)

1. Zocchi MR, Ferrarini M, Migone N, Casorati G (1994) T-cell receptor V delta gene usage by tumour reactive gamma delta T lymphocytes infiltrating human lung cancer. Immunology 81: 234-239.
2. Corvaisier M, Moreau-Aubry A, Diez E, Bennouna J, Mosnier JF, et al. (2005) V gamma 9V delta 2 T cell response to colon carcinoma cells. J Immunol 175: 5481-5488.
3. Todaro M, D'Asaro M, Caccamo N, Iovino F, Francipane MG, et al. (2009) Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. J Immunol 182: 7287-7296.
4. Takanami I, Takeuchi K, Giga M (2001) The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J Thorac Cardiovasc Surg 121: 1058-1063.
5. Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, et al. (1997) The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 79: 2320-2328.
6. Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Che X, et al. (2000) Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer 88: 577-583.
7. Welsh RM (1984) Natural killer cells and interferon. Crit Rev Immunol 5: 55-93.
8. Penninger JM, Wen T, Timms E, Potter J, Wallace VA, et al. (1995) Spontaneous resistance to acute T-cell leukaemias in TCRV gamma 1.1J gamma 4C gamma 4 transgenic mice. Nature 375: 241-244.
9. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, et al. (2001) Regulation of cutaneous malignancy by gammadelta T cells. Science 294: 605-609.
10. Benjamin TL (2001) Polyoma virus: old findings and new challenges. Virology 289: 167-173.
11. Swanson PA, 2nd, Lukacher AE, Szomolanyi-Tsuda E (2009) Immunity to polyomavirus infection: the polyomavirus-mouse model. Semin Cancer Biol 19: 244-251.
12. Allison AC, Law LW (1968) Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol Med 127: 207-212.
13. Law LW, Ting RC, Leckband E (1967) Prevention of virus-induced neoplasms in mice through passive transfer of immunity by sensitized syngeneic lymphoid cells. Proc Natl Acad Sci U S A 57: 1068-1075.
14. Allison AC, Monga JN, Hammond V (1974) Increased susceptibility to virus oncogenesis of congenitally thymus-deprived nude mice. Nature 252: 746-747.
15. Szomolanyi-Tsuda E, Welsh RM (1996) T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J Exp Med 183: 403-411.
16. Lukacher AE, Wilson CS (1998) Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein. J Immunol 160: 1724-1734.
17. Lukacher AE, Moser JM, Hadley A, Altman JD (1999) Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection. J Immunol 163: 3369-3378.
18. Berke Z, Palmer S, Bergman T, Wester D, Svedmyr J, et al. (1996) A short peptide eluted from the H-2Kb molecule of a polyomavirus-positive tumor corresponds to polyomavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity. J Virol 70: 3093-3097.
19. Lukacher AE, Ma Y, Carroll JP, Abromson-Leeman SR, Laning JC, et al. (1995) Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J Exp Med 181: 1683-1692.
20. Liunggren G, Liunggren HG, Dalianis T (1994) T cell subsets involved in immunity against polyoma virus-induced tumors. Virology 198: 714-716.
21. Wang B, Biron C, She J, Higgins K, Sunshine MJ, et al. (1994) A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci U S A 91: 9402-9406.
22. Drake DR, 3rd, Lukacher AE (1998) Beta 2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis. Virology 252: 275-284.
23. McCance DJ, Sebesteny A, Griffin BE, Balkwill F, Tilly R, et al. (1983) A paralytic disease in nude mice associated with polyoma virus infection. J Gen Virol 64(Pt 1): 57-67.
24. Szomolanyi-Tsuda E, Dundon PL, Joris I, Shultz LD, Woda BA, et al. (1994) Acute, lethal, natural killer cell-resistant myeloproliferative disease induced by polyomavirus in severe combined immunodeficient mice. Am J Pathol 144: 359-371.
25. Wilder JA, Yuan D (1995) Regulation of IFN-gamma mRNA production in murine natural killer cells. Int Immunol 7: 575-582.
26. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, et al. (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281: 65-78.
27. Watanabe N, Hizuta A, Tanaka N, Orita K (1995) Localization of T cell receptor (TCR)-gamma delta+T cells into human colorectal cancer: flow cytometric analysis of TCR-gamma delta expression in tumour-infiltrating lymphocytes. Clin Exp Immunol 102: 167-173.
28. Kowalczyk D, Skorupski W, Kwias Z, Nowak J (1996) Activated gamma/delta T lymphocytes infiltrating renal cell carcinoma. Immunol Lett 53: 15-18.
29. Viey E, Fromont G, Escudier B, Morel Y, Da Rocha S, et al. (2005) Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma. J Immunol 174: 1338-1347.
30. Bensussan A, Lagabrielle JF, Degos L (1989) TCR gamma delta bearing lymphocyte clones with lymphokine-activated killer activity against autologous leukemic cells. Blood 73: 2077-2080.
31. Choudhary A, Davodeau F, Moreau A, Peyrat MA, Bonneville M, et al. (1995) Selective lysis of autologous tumor cells by recurrent gamma delta tumorinfiltrating lymphocytes from renal carcinoma. J Immunol 154: 3932-3940.
32. Lozupone F, Pende D, Burgio VL, Castelli C, Spada M, et al. (2004) Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice. Cancer Res 64: 378-385.
33. Karre K, Ljunggren HG, Piontek G, Kiessling R (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675-678.
34. Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K (2000) Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356: 1795-1799.
35. Ruggeri L, Mancusi A, Burchielli E, Aversa F, Martelli MF, et al. (2007) Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. Curr Opin Oncol 19: 142-147.
36. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, et al. (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729.
37. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, et al. (2000) Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12: 721-727.
38. Carayannopoulos LN, Naidenko OV, Fremont DH, Yokoyama WM (2002) Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol 169: 4079-4083.
39. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH (1998) Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391: 703-707.
40. Wu J, Cherwinski H, Spies T, Phillips JH, Lanier LL (2000) DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J Exp Med 192: 1059-1068.
41. Rosen DB, Araki M, Hamerman JA, Chen T, Yamamura T, et al. (2004) A Structural basis for the association of DAP12 with mouse, but not human, NKG2D. J Immunol 173: 2470-2478.
42. Selin LK, Santolucito PA, Pinto AK, Szomolanyi-Tsuda E, Welsh RM (2001) Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J Immunol 166: 6784-6794.
43. Eagle RA, Trowsdale J (2007) Promiscuity and the single receptor: NKG2D. Nat Rev Immunol 7: 737-744.
44. Szomolanyi-Tsuda E, Le QP, Garcea RL, Welsh RM (1998) T-Cellindependent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles. J Virol 72: 6665-6670.
45. Dunn GP, Old LJ, Schreiber RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22: 329-360.
46. zur Hausen H (2008) Novel human polyomaviruses-re-emergence of a well known virus family as possible human carcinogens. Int J Cancer 123: 247-250.
47. Szomolanyi-Tsuda E, Seedhom MO, Carroll MC, Garcea RL (2006) T cellindependent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice. Virology 352: 52-60.
48. Welsh RM, Jr. (1978) Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med 148: 163-181.